| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Rajesh Madan B. Pharma CEO | XNSE Exchange | INE646B01010 ISIN |
| IN Country | 376 Employees | 19 Sep 2025 Last Dividend | - Last Split | - IPO Date |
Medicamen Biotech Limited is a distinguished entity in the pharmaceutical sector, entrenched in the vital process of researching, developing, manufacturing, marketing, selling, and distributing pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs) across India. With its foundations laid in 1993 and headquartered in New Delhi, India, the company has evolved into a pivotal player within the pharmaceutical industry. It prides itself on a broad portfolio of products that cater to a wide range of therapeutic areas, ensuring that it plays a significant role in enhancing healthcare standards and quality of life.
The product offerings of Medicamen Biotech Limited are diversified and tailored to meet the dynamic needs of the healthcare sector. Their comprehensive range encompasses:
The wide array of products is meticulously designed to address various therapeutic areas, including but not limited to gastrointestinal disorders, pain management, anti-infectives, pediatrics, dermatology, gynecology, rheumatology, diabetology, cardiology, oncology, and central nervous system ailments. This diverse product range underscores Medicamen Biotech Limited’s dedication to contributing significantly to the global healthcare landscape, through the provision of quality pharmaceutical solutions.